Modes of death and prognostic outliers in chronic heart failure

Marco Canepa1, Pietro Ameri1, Donata Lucci2

  • 1Cardiovascular Disease Unit, Policlinic Hospital San Martino IRCCS & Department of Internal Medicine, University of Genova, Genova, Italy.

American Heart Journal
|December 24, 2018
PubMed

Insights

Sudden cardiac death (SCD) impacts heart failure (HF) risk scores, especially in low-risk patients. New prognostic tools are needed for better accuracy in predicting HF mortality.

Area of Science:

  • Cardiology
  • Clinical Research
  • Heart Failure Management

Background:

  • Prognostic risk scores are crucial for managing chronic heart failure (HF).
  • The impact of sudden cardiac death (SCD) on the accuracy of these scores is not well understood.
  • Few studies have examined SCD's influence on risk prediction in HF patients.

Purpose of the Study:

  • To assess the relationship between predicted mortality and actual modes of death in chronic HF patients.
  • To evaluate how sudden cardiac death (SCD) affects the predictive accuracy of prognostic risk scores.
  • To identify predictors of death and survival in patients at the extremes of risk stratification.

Main Methods:

  • Utilized data from 6,859 participants in the GISSI-HF trial.
  • Estimated 3-year mortality using the MAGGIC risk score.
  • Analyzed the incidence of SCD and death from worsening HF across different risk categories.
  • Assessed the predictive accuracy of the MAGGIC model with and without SCD events.

Main Results:

  • Sudden cardiac death (SCD) was more common in lower-risk patients (52.5%) compared to higher-risk patients (23.5%).
  • Death from worsening heart failure (HF) was more frequent in higher-risk patients (46.1%) vs. lower-risk (19.7%).
  • Excluding SCD improved the MAGGIC model's predictive accuracy (AUC 0.731 to 0.760).
  • Independent predictors of death in low-risk patients included older age, longer HF history, higher uric acid, and COPD.
  • Higher systolic blood pressure was the sole predictor of survival in high-risk patients.

Conclusions:

  • The MAGGIC risk score has limited ability to account for sudden cardiac death (SCD), particularly in low-risk chronic heart failure (HF) patients.
  • Current prognostic tools may underestimate mortality risk in certain HF populations due to SCD.
  • There is a need for novel prognostic instruments to improve risk prediction in the evolving landscape of heart failure management.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
920
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.6K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
882
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
336
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
966
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
312